Home Celgene and Juno Announce Ten-Year Collaboration to Advance...
 

Keywords :   


Celgene and Juno Announce Ten-Year Collaboration to Advance...

2015-06-29 23:23:19| Biotech - Topix.net

Broad strategic collaboration leveraging combined immunology expertise and assets to develop and commercialize novel immunotherapies for the treatment of cancer and autoimmune diseases Celgene to make initial payment of approximately $1 billion which includes the purchase of ~9.1 million shares of Juno stock at $93.00 per share, with potential to increase its stake over time SUMMIT, N.J. & SEATTLE-- -- Celgene Corporation and Juno Therapeutics, Inc. announced today a global collaboration for the development and commercialization of immunotherapies.

Tags: advance collaboration announce juno

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
30.06Hurricane Beryl Update Statement
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Forecast Discussion Number 8
30.06Hurricane Beryl Public Advisory Number 8
30.06Hurricane Beryl Wind Speed Probabilities Number 8
30.06Hurricane Beryl Forecast Advisory Number 8
30.06Weekly Recap: Rockline Wins WOW Innovation Award, Hospeco Purchases Nuance Solutions & More
More »